New Delhi, Dec 17 (UNI) In a bid to control the quality of medicinal products in the country, the Indian Pharmacopoeia which would enable inspection and licensing of manufacturing and distribution of drugs and pharmaceuticals, will be launched tomorrow.
Health Minister Anbumani Ramadoss would launch Indian Pharmacopoeia 2007 that would play a vital role in initiating new prospective for improving the quality of medicines and accelerate development of pharma sector in the country.
The Pharmacopoeia has been produced for fulfiling the requirements under the Drugs and Cosmetics Rules, 1945. The standards of this Pharmacopoeia are authoritative and legally enforceable. The principle of ''openness, justice and fairness'' has been kept in mind during compiling and editing of the document.
The Pharmacopoeia has been prepared in accordance with the principles and designed plan decided by the Scientific Body of the Indian Pharmacopoeia Commission.
In addition to the past practices of requesting for comments, the contents of revised appendices and monographs have been publicised on the website of the Indian Pharmacopoeia Commission, for collecting comments widely from various institutions and organisations. All the feedback and inputs have been reviewed by the relevant Expert Committee to ensure the feasibility and practicability of the standards and methods revised in this edition of the Pharmacopoeia published in three volumes.
The Pharmacopoeial standards included in this publication adhere to the concept of harmonisation with those used internationally, also keeping in view technological status for manufactures and analysis of different sectors of the industry, without compromising with the quality of the products.
It is hoped that this publication would be able to fulfill the Mission of the Indian Pharmacopoeia Commission to promote public health both in India and other countries through drugs manufactured in the country.